Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-21
2011-06-21
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S171000
Reexamination Certificate
active
07964599
ABSTRACT:
Compounds comprisingor a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J, B, Y, and A are as described.Methods, compositions, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 4166452 (1979-09-01), Generales
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen
patent: 6437146 (2002-08-01), Hattori
patent: 6710072 (2004-03-01), Burk
patent: 2003/0130239 (2003-07-01), Burk
patent: 2007/0129552 (2007-06-01), Donde
patent: WO 2006/063179 (2006-06-01), None
Carey, Francis A.: Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Lal, Gauri; et al.: Bis(2-methoxyethyl)aminosulfur Trifluoride: A New Broad-Spectrum Deoxofluorinating Agent with Enhanced Thermal Stability. J. Org. Chem. 1999, 64, 7048-7054.
Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, Pa., 16thEdition, 1980.
Tani, K. et al. (ONO) Bioorganic and Medicinal Chemistry 2002, 10, 1883.
U.S. Appl. No. 60/742,779, filed Dec. 6, 2005, Donde.
U.S. Appl. No. 60/746,275, filed May 3, 2006, Donde.
U.S. Appl. No. 60/747,835, filed May 22, 2006, Donde.
U.S. Appl. No. 11/009,298, filed Dec. 10, 2004, Donde.
Donde Yariv
Nguyen Jeremiah H.
Allergan Inc.
Anderson Rebecca L
Ene Doina G.
Forrestal Kevin J.
Wurst John E.
LandOfFree
Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2633850